Journal of Clinical Virology

Article	Citations
Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19	734
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past	646
Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis	454
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis	437
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China	409
Evaluation of rapid antigen test for detection of SARS-CoV-2 virus	378
Comparison of seven commercial RT-PCR diagnostic kits for COVID-19	360
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients	285
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome	282
Epidemiology and clinical features of COVID-19: A review of current literature	269
COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being	249
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study	237
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies	222
Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies	211
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immu	195
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms	185
The clinical course and its correlated immune status in COVID-19 pneumonia	185
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation	168
Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2	164
Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays	161
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2	153
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays	136
Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients	134
Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19	129
Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study	126

Clinical characteristics and risk assessment of newborns born to mothers with COVID-19	125
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu	123
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic	123
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care	121
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG	115
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review	114
Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis	108
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection	107
Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays	103
Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China	102
Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19	94
Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories	94
Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2	91
Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?	90
Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China	90
Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic	88
Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification	88
Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis	86
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutrali	86
Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19	85
Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China	85
Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2	85
Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus	84
SARS-CoV-2 detection by direct rRT-PCR without RNA extraction	80
High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2	80
Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria	80
Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening	79
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies	78
Evaluation of the COVID19 ID NOW EUA assay	78
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test	77
A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2	70
Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests	70
Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates	69
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect	69
Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials	68
Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays	68
Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2	68
Clinical features of pediatric patients with coronavirus disease (COVID-19)	67
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay	66
Validation of SARS-CoV-2 detection across multiple specimen types	62
Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection	62
Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV	61
Challenges of Convalescent Plasma Therapy on COVID-19	61
Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study	61
Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis	59
Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection	59
SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons	58
Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19	56
Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers	55
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients	55

Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2	55
Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2	55
Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19	54
Comparison of SARS-CoV-2 serological tests with different antigen targets	54
Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting	52
Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion	52
Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes	51
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody	51
Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits	51
Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients	51
SARS-CoV-2 viral load assessment in respiratory samples	50
Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan	49
Pooling of SARS-CoV-2 samples to increase molecular testing throughput	49
Modeling the effects of intervention strategies on COVID-19 transmission dynamics	48
Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: A cross-sectional study	46
Another false-positive problem for a SARS-CoV-2 antigen test in Japan	46
SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus	45
Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital	45
A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance	45
A predictive tool for identification of SARS-CoV-2 PCR-negative emergency department patients using routine test results	44
Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2	44
Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test	44
Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study	44
Comparison of different serological assays for SARS-CoV-2 in real life	44
Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection	43
Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis	43
Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort	43
Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance	43
Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay	41
Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus	40
Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure	39
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection	39
SARS-CoV-2: Is it the newest spark in the TORCH?	39
Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study	39
Recommendations for the introduction of metagenomic next-generation sequencing in clinical virology, part II: bioinformatic analysis and reporting	38
First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences	38
Maternal type of CMV infection and sequelae in infants with congenital CMV: Systematic review and meta-analysis	38
Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples	38
Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus.	37
Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2	37
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay	36
Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19	36
Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR	36
Development of a point-of-care test to detect SARS-CoV-2 from saliva which combines a simple RNA extraction method with colorimetric reverse transcription loop-mediated isothermal amplification detect	35
A RT-PCR assay for the detection of coronaviruses from four genera	35
Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR)	35
Single-step RT-PCR assay for dual genotyping of GI and GII norovirus strains	34
Improved diagnosis of viral encephalitis in adult and pediatric hematological patients using viral metagenomics	34
Human parainfluenza virus circulation, United States, 2011–2019	33
Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection	33
SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England	33
Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays	33
Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR	33
Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studies	32
Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit – High mortality rate in infected patients with haematologic malignancies	32
Acute bronchiolitis and respiratory syncytial virus seasonal transmission during the COVID-19 pandemic in Spain: A national perspective from the pediatric Spanish Society (AEP).	32
Five-minute point-of-care testing for SARS-CoV-2: Not there yet	32
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19	32
Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study	31
Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT	31
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.	30
Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures	30
Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants	30
Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario	29
Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study	29
SARS-CoV-2 infection among asymptomatic healthcare workers of the emergency department in a tertiary care facility	29
Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples	28
Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection	28
Human Calicivirus Typing tool: A web-based tool for genotyping human norovirus and sapovirus sequences	28
Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge	28
Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domai	28
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design	28
Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens	28
Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness	28
Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19	27
Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity	27
Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection	27
Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement	27
ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease	26
Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes	26

Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?	26
Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant	26
Human Bocavirus infection and respiratory tract disease identified in a UK patient cohort	25
Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay	25
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2	25
Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections	25
Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19	25
Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection	25
Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommen	25
Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7	24
Dynamics of IgG-avidity and antibody levels after Covid-19	24
COVID-19 in Vietnam: A lesson of pre-preparation	23
Rapid screening method for the detection of SARS-CoV-2 variants of concern	23
Comparison of the GeneFinderTM COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITe InGenius to the national reference method: An added value of N gene target detection?	23
Rapid and simultaneous identification of three mutations by the Novaplex™ SARS-CoV-2 variants I assay kit	22
Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay	22
Evolution of awareness and knowledge of congenital cytomegalovirus infection among health care providers in France between 2011 and 2018	22
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests	21
RSV reemergence in Argentina since the SARS-CoV-2 pandemic	21
Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity	21
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)	21
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test	20
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers	20
Extraction-free RT-LAMP to detect SARS-CoV-2 is less sensitive but highly specific compared to standard RT-PCR in 101 samples	20
Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020	20
Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design	20
Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory	20
Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: A case-series	19
Comparative evaluation of SARS-CoV-2 IgG assays in India	19
Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study	19
Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis	19
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study	19
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection	19
Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients	18
SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis.	18
Redondovirus DNA in human respiratory samples	18
Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department	18
Correlation between monkeypox viral load and infectious virus in clinical specimens	17
The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing	17
Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response	17
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2	17
RT-PCR based SARS-CoV-2 variant screening assays require careful quality control	17
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis	17
The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China	16
Human coronaviruses: Origin, host and receptor	16
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens	16
Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain	16
Comparison of SARS-CoV-2 detection from combined nasopharyngeal/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument	16
The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test	16
Enterovirus D68 outbreak detection through a syndromic disease epidemiology network	16
Unusual, neurological and severe dengue manifestations during the outbreak in Sri Lanka, 2017	16
Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults	16
Improved oral detection is a characteristic of Omicron infection and has implications for clinical sampling and tissue tropism	15
Highly sensitive and specific detection of the SARS-CoV-2 Delta variant by double-mismatch allele-specific real time reverse transcription PCR	15
Case fatality rate in patients with COVID-19 infection and its relationship with length of follow up	15
Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection	15
SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility	15
Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)	15
A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay	15
Epidemiological characteristics and clinical outcomes of human rhinovirus infections in a hospitalized population. Severity is independently linked to RSV coinfection and comorbidities	15
CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting	15
Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients	14
Insights into immune evasion of human metapneumovirus: novel 180- and 111-nucleotide duplications within viral G gene throughout 2014-2017 seasons in Barcelona, Spain	14
Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting	14
Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples	14
Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay	14
Evaluation of sixteen ELISA SARS-CoV-2 serological tests	14
Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein	14
Comprehensive pathogen detection for ocular infections	14
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses	14
Implementation of an in-house real-time reverse transcription-PCR assay to detect the emerging SARS-CoV-2 N501Y variants	14
Validation and implementation of an orthopoxvirus qualitative real-time PCR for the diagnosis of monkeypox in the clinical laboratory	14
Atypical hand-foot-mouth disease in Belém, Amazon region, northern Brazil, with detection of coxsackievirus A6	14
Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans	14
Increasing horizontal transmission of human T-cell leukemia virus type 1 in adolescents and young adults in Japan	14
Droplet digital PCR quantification suggests that higher viral load correlates with improved survival in HPV-positive oropharyngeal tumours	14
Evaluation and clinical validation of monkeypox (mpox) virus real-time PCR assays	13
Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays	13
Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study	13
“The effectiveness of rapid antigen test-based for SARS-CoV-2 detection in nursing homes in Valencia, Spain”	13
The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong	13
Human adenovirus species in children with acute respiratory illnesses	13
Increasing prevalence of HPV in oropharyngeal carcinoma suggests adaptation of p16 screening in Southeast Asia	13
Assessing the burden of viral co-infections in acute gastroenteritis in children: An eleven-year-long investigation	13
Development of a β-HPV vaccine: Updates on an emerging frontier of skin cancer prevention	13
Evaluation of the Xpert HBV Viral Load for hepatitis B virus molecular testing	13
Clinical performance and sample freeze-thaw stability of the cobas®6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens	13
Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline	13
Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus	12
Genetic diversity and molecular epidemiology of respiratory syncytial virus circulated in Antananarivo, Madagascar, from 2011 to 2017: Predominance of ON1 and BA9 genotypes	12
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study	12
Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department	12
Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: May it help to predict clinical outcomes?	12
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations	12
Pooled Testing for Surveillance of SARS-CoV-2 in Asymptomatic Individuals	12